How drug pricing proposals would lower costs

A recent survey found 80 percent of American adults believe prescription drugs are unreasonably expensive, and almost 90 percent of adults in the United States support government drug price negotiation. Currently, there are several proposals gaining speed at the federal level. One of the proposals would allow the U.S. Department of Health and Human Services to negotiate drug prices. Another one would prevent drug companies from raising their prices at a rate faster than inflation and adding a cap on out-of-pocket payments for prescription drugs for Medicare beneficiaries. The attached issue brief by Nicole Rapfogel, Maura Calsyn, and Colin Seeberger of the Center for American Progress outlines just some of the ways that drug pricing reform would help consumers and businesses. Read the issue brief here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org